Clin Asst Prof Lim Chong Teik Thomson

Dr. Thomson Lim is a gastroenterologist who completed his specialist training in Gastroenterology and Hepatology in 2020. He was subsequently awarded the Health Manpower Development Plan (HMDP) award to further develop his subspecialty interest in Intestinal Ultrasound and Inflammatory Bowel Disease. As part of this award, he completed a fellowship at Amsterdam University Medical Centre in the Netherlands, where he gained advanced training in intestinal ultrasound and IBD management.

Dr. Lim is actively involved in advancing intestinal ultrasound education and clinical practice. He has helped establish Singapore General Hospital as a training centre for intestinal ultrasound and supports internationally accredited training programs such as IBUS, GENIUS and ESPGHAN. He is also a visiting consultant at KK Women’s and Children’s Hospital, where he supports the transition program for patients with inflammatory bowel disease moving from paediatric to adult care. His clinical interests include inflammatory bowel disease, intestinal ultrasound, and the use of advanced imaging techniques to improve patient care.

• M. Med (Int Med), National University of Singapore, School of Medicine (2015)
• MRCP (UK), Royal Colleges of Physicians of the United Kingdom (2015)
• MD (UKM) , National University of Malaysia (2011)

• International Bowel Ultrasound (IBUS) Group Ambassador (2026)
• Singapore General Hospital Ultrasound Workgroup Committee (2024)

• SingHealth Health Manpower Development Plan (HMDP) Fellowship Award “Intestinal ultrasound in IBD: A vital point of care service in advancement of outpatient care in IBD” (2023)
• Service with a Heart (2022)

• Lim CT, Teichert C, Pruijt M, Voogd Fd, d’Haens G, Gecse K. Transmural healing in ulcerative colitis patients improves long-term outcomes compared to endoscopic healing alone. J of Crohn’s and Colitis. 2025 Aug. doi: 10.1093/ecco-jcc/jjaf149
• Lim CT, Teichert C, Gecse K. Beyond the mucosa: Intestinal ultrasound for post endoscopic healing risk stratification in ulcerative colitis – Authors’ reply. J of Crohn’s and Colitis. 2025 Nov. doi: 10.1093/ecco-jcc/jjaf199
• Cai SH, Lim CT, Tan YY, Tay YX, Cheong EHT, Tan MTK. Intestinal ultrasound for Crohn’s disease: A single-centre experience in cost and carbon emissions reduction through transdisciplinary collaboration. Radiography. 2025 Aug. doi: 10.1016/j.radi.2025.103114
• Tan YY, Cheong EHT, Lim CT, Cai SH, Tay SW, Leong J, Salazar E, Cheng LTE, Low ASC, Tan MTK. Clinical and environmental impact of intestinal ultrasound for inflammatory bowel disease: a tertiary centre experience in Southeast Asia. Scan J of Gastro 2025 Jul. doi: 10.1080/00365521.2025.2533338
• Lim CT, Tay SW, Elangovan S, Ong WC, Lim GH, Salazar E, Chan WPW, Tan MTK. Long-term effectiveness and persistence rate of ustekinumab dose intensification in a South East Asian inflammatory bowel disease center. J Gastroenterol Hepatol. 2024 Apr 28. doi: 10.1111/jgh.16562
• Lim CT, Salazar E, Tan MTK, Chan W. Inflammatory Bowel Disease – An update for primary care physicians. Singapore Fam Physician. 2022; 48(1):49-58. doi: 10.33591/sfp.48.1.uo1
• Ong WC, Lim MS, Chan E, Lim CT, Lim TG, Chan W - A quality improvement project reduces time spent at an inflammatory bowel disease infusion center with accelerated infliximab infusion protocol. JGH Open. 2022 Jun 1;6(7):470-476. doi: 10.1002/jgh3.12776
• Tan M, Ng V, Lim CT, Leow WQ, Chan W. Stringent criteria for withdrawal of biologics in ulcerative colitis. Lancet Gastroenterol Hepatol. 2021 Sep;6(9):687-688. doi: 10.1016/S2468-1253(21)00181-3.
• Lim CT, Goh GBB, Li H, Lim TK, Leow WQ, Wan WK, Azhar R, Chow WC, Kumar R. Presence of Hepatic Steatosis Does Not Increase the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Over Long Follow-Up. Microbiol Insights. 2020 May doi: 10.1177/1178636120918878
• Lim CT, Kumar R. Hepatitis B and concomitant hepatic steatosis. Ann Transl Med. 2017 Feb;5(3):38. doi: 10.21037/atm.2016.12.04.